NUVECTIS PHARMA, INC.

Insiders Nuvectis Pharma, Inc.

Equities

NVCT

US67080T1088

Market Closed - Nasdaq Other stock markets 21:00:00 28/05/2024 BST			5-day change	1st Jan Change
6.58 ^USD	+5.96%		+8.22%	-21.10%

05-07	Nuvectis Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-08	Nuvectis Pharma's Nxp900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Insider Buy: Nuvectis Pharma	27/07/23	MT
Insider Buy: Nuvectis Pharma	24/07/23	MT
Insider Buy: Nuvectis Pharma	20/07/23	MT
Insider Buy: Nuvectis Pharma	19/07/23	MT
Insider Buy: Nuvectis Pharma	12/07/23	MT
Insider Buy: Nuvectis Pharma	10/07/23	MT
Insider Buy: Nuvectis Pharma	27/06/23	MT
Insider Buy: Nuvectis Pharma	26/06/23	MT
Insider Buy: Nuvectis Pharma	20/06/23	MT
Insider Buy: Nuvectis Pharma	16/06/23	MT
Nuvectis Pharma, Inc Announces Formation of A Scientific Advisory Board	28/09/22	CI
Insider Buy: Nuvectis Pharma	22/08/22	MT
Insider Buy: Nuvectis Pharma	16/08/22	MT
Insider Buy: Nuvectis Pharma	16/05/22	MT
Insider Buy: Nuvectis Pharma	13/05/22	MT
Insider Buy: Nuvectis Pharma	09/02/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer